Action Research Collaborative aiming for results – now

Professors Neil Lewis Jr. ’13 and Tashara Leak are leading the new Action Research Collaborative, which will serve as an institutional hub for cross-campus action research collaborations between Ithaca and New York City, and elsewhere.

Staff News

Flu, measles vaccines could help flatten COVID curve

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.

Best time for COVID vaccination in pregnancy may be now

COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine.

Lymphoma cell metabolism may provide new cancer target

Aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from Cornell researchers.

arXiv hits 2M submissions

The research-sharing platform is a free resource for scholars around the world in fields including physics, math and computer science, who use the service to share their own cutting-edge research and read work submitted by others.

Researchers find promising new target for TB treatment

Mycobacterium tuberculosis, the hardy bacterial species that causes tuberculosis, has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine.

Effort to combat physician burnout shows progress

Following a sweeping effort in 2019 to address clinical care team well-being across Weill Cornell Medicine, physicians note a reduction in stress and feelings of burnout compared to previous surveys, according to a new report from the institution.

Alternative statistical method could improve clinical trials

An alternative statistical method honed and advanced by Cornell researchers can make clinical trials more reliable and trustworthy while also helping to remedy what has been called a “replicability crisis” in the scientific community.

New approach to analyzing genetics underlying spina bifida

Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.